Programme de prévention et de gestion des maladies cardiovasculaires

Objectives

Morocco’s 2018–2021 cardiovascular disease programme seeks to reduce avoidable mortality, disability, impaired quality of life and socio-economic harm from cardiovascular and cerebrovascular disease through an integrated response spanning prevention, early detection, emergency treatment, chronic-care coordination, rehabilitation and palliative care.[1][2][3]It addresses cardiovascular determinants and risk factors, heart and vascular disease, and stroke across the full pathway from healthy status and risk exposure to acute episodes, long-term illness, frailty and advanced disease.[4][5][6]

• Reduce population cardiovascular risk through coordinated action on tobacco use, unhealthy diet and salt intake, physical inactivity, obesity, hypertension, dyslipidaemia, diabetes, harmful alcohol use, pollution and psychosocial stress.[7][8][9]
• Promote health education, healthy eating, physical activity, patient information, therapeutic education, self-care and family involvement, with attention to children, young adults, women and other priority groups.[8][10][11]
• Detect risk factors early and provide validated cardiovascular-risk assessment and stratification, particularly for people at high or very high risk and those with established cardiovascular disease.[10][12]
• Strengthen integrated primary-care and general-practice management of hypertension, diabetes, acute rheumatic fever and other cardiovascular risks, rather than maintaining fragmented disease-specific programmes.[13][14][15]
• Improve responses to acute coronary syndrome and stroke through public recognition of emergency symptoms, rapid transport, timely reperfusion, thrombolysis, angioplasty, brain imaging and thrombectomy where indicated.[16][12][17][18]
• Coordinate four principal care pathways for ischaemic heart disease, neurovascular disease, rheumatic valvular disease and heart failure, while strengthening rehabilitation, geriatric care, home follow-up and palliative care.[18][19][20]

The strategic framework sets three principal orientations: prevent and reduce risks before disease develops; improve management of cardiovascular and neurological emergencies and acute episodes; and coordinate care for people with cardiovascular disease or high cardiovascular risk.[11]A fourth area covers implementation, governance and partnership.[20][21]The plan aims by 2025 to reduce high cardiovascular-risk prevalence by 25%, tobacco prevalence by 15%, insufficient physical activity by 5%, and population salt consumption by approximately 15%.[11][12]It also aims for 50% of primary-care patients aged over 45 to receive a validated risk assessment, to halve one-month mortality from cardiovascular and neurological attacks among people under 70, and to reduce mortality and major events among high-risk patients.[12][18][22]

Implementation

Implementation combines population-wide prevention with risk-based clinical management, organised care pathways and strengthened service capacity across primary, secondary and tertiary care.[23][11][24]The programme was developed through epidemiological and service evidence, field visits, interviews, multidisciplinary shared diagnosis, stakeholder workshops and consultation with Ministry of Health directorates, professional societies, health insurance bodies, regional authorities, patients and international partners including the World Health Organization.[25][26][3][27]

• Use the World Health Organization Global Hearts and HEARTS approaches, initially through pilot sites, to support protocols, algorithms, training, operational management and integrated cardiovascular-risk management in primary health care.[10][12]
• Equip primary-care facilities with essential cardiovascular medicines, blood-pressure and glucose measurement, glycated-haemoglobin testing, electrocardiography, laboratory access, decision-support tools and patient registers.[28][29][9]
• Train doctors, nurses, general practitioners, community and rehabilitation staff in risk assessment, communication, therapeutic education, emergency care, referral, follow-up and multidisciplinary management.[5][30][31]
• Organise referral and counter-referral between primary care, specialists, hospitals, emergency transport and community services, with the general practitioner or family doctor acting as a continuing-care coordinator.[10][6][19]
• Develop regional and interregional emergency networks, including electrocardiogram teletransmission, local thrombolysis, specialised cardiac and neurovascular centres, and phased pilots before national extension.[32][33][34]
• Strengthen clinical and facility information systems to link patient records, risk-stratified follow-up, management registers and activity monitoring across primary-care and hospital structures.[5][20][35]
• Use public-private partnerships selectively where public specialist provision is persistently insufficient, under contractual conditions covering eligible patients, service scope, duration, pricing, compliance, evaluation and possible sanctions.[33][36]

Governance is envisaged through a Ministry of Health project team, an intersectoral steering committee, the cardiovascular diseases committee, regional directorates and coordination meetings, supported where needed by technical assistance.[21]Delivery requires collaboration across health, education, finance, interior, transport, urban planning, food industry, media, civil society, local authorities, professional and scientific societies, health insurance bodies and private providers.[8][37][36]The programme also seeks to involve service users and patients in governance and programme design.[38][39]

Monitoring is intended to use an annual implementation roadmap and dashboard, national reporting, primary-care and hospital activity information, clinical follow-up records and quality indicators, including coverage of risk scoring, follow-up plans and personalised care plans.[22][34][21]Pilot high-risk management and partnership arrangements are to be evaluated before wider scale-up.[34][36]Although targets and several monitoring mechanisms are specified, the supplied material does not provide a consolidated indicator dictionary, reporting timetable, evaluation methodology or complete accountability framework.[16][21]

Financing requires budgeting operational measures, securing favourable government allocations, mobilising partner and civil-society contributions, and considering health-insurance tariffs or bundled payments for coordinated pathways.[20][21][39]Resource priorities include workforce recruitment and distribution, training, medicines, equipment, maintenance, information systems, emergency technical platforms and rehabilitation capacity.[5][33][40]No quantified overall budget, funding gap or detailed financing plan is specified in the supplied material.[21][39]

Monitoring & Evaluation

The programme combines epidemiological assessment, service-activity monitoring, patient follow-up and implementation review, but the supplied material does not set out one fully consolidated monitoring and evaluation framework with standard definitions, data sources, reporting cycles and accountability arrangements.[28][20][21]

• Monitor cardiovascular risk and clinical care through validated risk scores, including assessment of age, sex, smoking, systolic blood pressure and cholesterol, to stratify patients and tailor treatment and follow-up.[23][10]
• Integrate clinical records, patient registers, risk-stratified follow-up and facility-activity monitoring within unified health information systems across primary care and hospitals.[5][34][35]
• Strengthen surveillance by improving knowledge of cardiovascular risk factors, disease prevalence and service availability, while reviewing the reliability of death-cause reporting and addressing incomplete information on private-sector activity.[41][35][42]
• Track 2025 results targets, including a 25% reduction in high cardiovascular-risk prevalence, a 15% reduction in tobacco prevalence, a 5% reduction in insufficient physical activity, an approximately 15% reduction in salt consumption, and cardiovascular-risk assessment for 50% of primary-care patients aged over 45.[11][12]
• Measure emergency-care outcomes through the target to halve one-month mortality from cardiovascular and neurological attacks among people under 70, alongside access within defined times to thrombolysis, coronary angioplasty, stroke imaging and stroke treatment.[12][17][18]
• Assess continuity of care through proposed indicators for compliant medical and educational follow-up plans among high-risk patients, personalised plans for frail patients, and individualised pathway plans for diagnosed patients.[18][19][22]
• Evaluate pilot implementation before national scale-up, notably for integrated high-risk management in primary care and regional pathway models.[33][34][20]
• Use an annual implementation roadmap and dashboard, national reporting, regional coordination meetings and advice from the cardiovascular diseases committee to support programme steering.[21]
• Apply oversight to public-private arrangements through contractual conditions, evaluation of compliance and possible termination or sanctions where obligations are breached.[33][36][42]

Evidence development includes risk-factor studies, a prevalence study launched in 2017, hospital activity data, field visits, stakeholder interviews and multidisciplinary diagnostic workshops.[43][26][44]Reporting frequency, independent evaluation methods, a complete indicator dictionary, named data custodians and formal accountability bodies are generally not specified beyond the mechanisms above.[16][21][45]

Costing & Financing

The supplied material identifies significant resource needs and financing pressures but provides no total programme cost, detailed budget, quantified funding gap, financing timetable or economic model.[21][39][15]Prevention is presented as economically important because advanced chronic disease and acute complications create substantial costs for households, insurers and public services.[46][7]

• Recognise that households accounted for 54% of health expenditure in 2010, indicating substantial out-of-pocket payment exposure.[46]
• Address expenditure concentration in compulsory or mandatory health insurance, where 50% of spending in 2012 was directed to 3% of affiliates or insured people with long-term conditions.[46][47]
• Budget operational measures and seek favourable government decisions on a dedicated programme budget, while prioritising feasible actions.[48][21]
• Mobilise contributions from civil society, non-governmental organisations, international partners, health insurance bodies and other public or private partners, without quantified commitments.[49][36][50]
• Consider tobacco taxation and proposed taxes on industries that do not meet health objectives as possible prevention and care financing mechanisms; no rates, revenues or allocation rules are provided.[37]
• Invest in staffing, professional training, medicine supply, laboratory capacity, equipment, maintenance, information systems, telemedicine, rehabilitation, palliative care and regional care networks.[5][33][51]
• Plan costly specialised services, including interventional cardiology, interventional neurology and cardiac and cerebral revascularisation, by balancing capital and operating requirements against equitable territorial access and treatment-time needs.[16][33][52]
• Use public-private contracting only where public services are persistently insufficient, with defined service scope, eligible populations, affordability conditions, limited duration and regulatory oversight.[33][36]
• Explore health-insurance tariffs for individual acts or bundled pathway payments to support coordinated care, although no tariff values or payment design are specified.[20]

Cost-related risks include the expense and availability of laboratory testing and thrombolytic medicines, high establishment costs for interventional centres, medicine stock-outs, workforce shortages and the reported high cost of rehabilitation and palliative care.[32][49][33][51]The material also suggests that better coordination could reduce avoidable readmissions and that home-based palliative care may be less costly than hospital care, but supplies no quantified savings estimates.[38][53]